AbbVie Inc (ABBV)
Net profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 4,278,000 | 4,863,000 | 11,836,000 | 11,542,000 | 4,616,000 |
| Revenue | US$ in thousands | 56,334,000 | 54,318,000 | 58,054,000 | 56,197,000 | 45,804,000 |
| Net profit margin | 7.59% | 8.95% | 20.39% | 20.54% | 10.08% |
December 31, 2024 calculation
Net profit margin = Net income ÷ Revenue
= $4,278,000K ÷ $56,334,000K
= 7.59%
AbbVie Inc's net profit margin has shown some fluctuations over the past few years. In December 2020, the net profit margin stood at 10.08%, showing a significant increase to 20.54% by December 2021. The margin remained relatively stable in December 2022 at 20.39%. However, there was a notable decrease in December 2023 to 8.95% and a further decline to 7.59% by December 2024.
The increase in net profit margin from 2020 to 2021 indicates improved efficiency in cost management and revenue generation. The stable margin in 2022 suggests continued operational effectiveness. The decrease in 2023 and 2024 may raise concerns about factors impacting profitability such as increased costs, declining revenues, or other operational challenges.
Overall, while AbbVie Inc has demonstrated strong profitability in recent years, investors and stakeholders may need to monitor the company's financial performance closely to understand the factors leading to the fluctuations in net profit margin.
Peer comparison
Dec 31, 2024